# ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction

Study · id `cardio:ct-nct07020702` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07020702](<https://clinicaltrials.gov/study/NCT07020702>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07020702

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Heart failure; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

## Technical summary

Registry record NCT07020702. Non-randomized; no masking; primary purpose prevention. Start 2023-06-12 (actual); primary completion 2030-09-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 210 participants (planned count; ClinicalTrials.gov record NCT07020702, source copy `cardio:ctgov-nct07020702-2025-07-10`, retrieved 2026-10-26)
- Started: 2023-06-12 (actual) (ClinicalTrials.gov record NCT07020702, source copy `cardio:ctgov-nct07020702-2025-07-10`, retrieved 2026-10-26)
- Primary completion: 2030-09-12 (anticipated) (ClinicalTrials.gov record NCT07020702, source copy `cardio:ctgov-nct07020702-2025-07-10`, retrieved 2026-10-26)
- Completion: 2030-09-12 (anticipated) (ClinicalTrials.gov record NCT07020702, source copy `cardio:ctgov-nct07020702-2025-07-10`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT07020702, source copy `cardio:ctgov-nct07020702-2025-07-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07020702-2025-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction
- Acronym: EP-SCOPE
- Condition: Ventricular Arrhythmia
- Condition: Cardiomyopathies
- Condition: Left Ventricular Ejection Fraction Less Then or Equal to 50percent
- Intervention (Device): Implantation of an ICD
- Lead sponsor: University Hospital, Bordeaux
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: University Hospital, Bordeaux (`cardio:org-university-hospital-bordeaux`)

## Provenance

Content hash: 8a06b18ab344b3d07b25fe882d2949870725f1682d5644ca961c78f081321e75
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
